Docetaxel, with or without estramustine phosphate, as first-line chemotherapy for hormone-refractory prostate cancer: results of a multicentre, randomized phase II trial.
| Image |  |
|---|---|
| Description | scientific article published on 15 May 2008 |
| Author/s |
author: Orazio Caffo |
| Publication date | May 15, 2008 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |